Pathogenetic concepts of membranous glomerulopathy (MGN)
- PMID: 11132040
Pathogenetic concepts of membranous glomerulopathy (MGN)
Abstract
Membranous glomerulopathy (MGN) is a frequent cause for nephrotic syndrome in adults. In this overview, the basic pathogenic features of Heymann nephritis, a "classical" model of MGN in rats, are compared with those of human MGN. While the pathogenic antigen(s) of rat Heymann nephritis (the polyspecific receptor protein gp330/megalin), and that of human MGN (unknown) are obvioulsy different, the results indicate that the molecular mechanisms of proteinuria may be similar in both instances and involve the formation of lipid peroxidation adducts in the glomerular capillary filter. As a consequence, probucol - an efficient inhibitor of lipid peroxidation - drastically reduces proteinuria both in Heymann nephritis and in a large proportion of human patients with MGN.
Similar articles
-
Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).J Am Soc Nephrol. 1996 Dec;7(12):2518-26. doi: 10.1681/ASN.V7122518. J Am Soc Nephrol. 1996. PMID: 8989729 Review.
-
Megalin/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN).Kidney Blood Press Res. 2000;23(3-5):163-6. Kidney Blood Press Res. 2000. PMID: 11031710 Review. No abstract available.
-
Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.Am J Pathol. 1994 Apr;144(4):807-19. Am J Pathol. 1994. PMID: 8160779 Free PMC article.
-
Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.J Pathol. 2006 Nov;210(3):282-7. doi: 10.1002/path.2058. J Pathol. 2006. PMID: 16981232
-
Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.J Clin Invest. 1994 Oct;94(4):1577-84. doi: 10.1172/JCI117499. J Clin Invest. 1994. PMID: 7929834 Free PMC article.
Cited by
-
Rituximab in idiopathic membranous nephropathy.J Am Soc Nephrol. 2012 Aug;23(8):1416-25. doi: 10.1681/ASN.2012020181. Epub 2012 Jul 19. J Am Soc Nephrol. 2012. PMID: 22822077 Free PMC article. Clinical Trial.
-
Experimental membranous nephropathy redux.Am J Physiol Renal Physiol. 2005 Oct;289(4):F660-71. doi: 10.1152/ajprenal.00437.2004. Am J Physiol Renal Physiol. 2005. PMID: 16159900 Free PMC article. Review.
-
Pathogenesis of membranous nephropathy: recent advances and future challenges.Nat Rev Nephrol. 2012 Feb 28;8(4):203-13. doi: 10.1038/nrneph.2012.35. Nat Rev Nephrol. 2012. PMID: 22371247 Review.
-
A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.Pflugers Arch. 2017 Aug;469(7-8):997-1005. doi: 10.1007/s00424-017-2007-x. Epub 2017 Jun 8. Pflugers Arch. 2017. PMID: 28597189 Review.
-
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.J Nephrol. 2018 Apr;31(2):271-278. doi: 10.1007/s40620-017-0451-5. Epub 2017 Oct 28. J Nephrol. 2018. PMID: 29081027
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials